Bishop John E — SEC insider filings
SEC reporting owner CIK 1308911. 10 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2021-06-15 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 3 filings — 25,235 shares, $109,213 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 17,281 shares @ $3.86 ($66,651) in ARDELYX, INC., filed 2026-08-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARDELYX, INC. (ARDX) | See Remarks | 5 | — | 6 legs · 25,235 sh · $109,213 | 3 |
| Forma Therapeutics Holdings, Inc. (FMTX) | SVP, Chief Technology Officer | 3 | — | — | 7 |
| Lyra Therapeutics, Inc. (LYRA) | Chief Technology Officer | 2 | — | — | 2 |
Insider filings — Bishop John E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | ARDELYX, INC. (ARDX) | Tax withholding (F): 6,413 @ $3.06 | EDGAR |
| 2026-08-25 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 17,281 @ $3.86 · Sale (S): 2,469 @ $3.86 | EDGAR |
| 2026-05-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 2,306 @ $6.27 | EDGAR |
| 2026-02-23 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 2,792 @ $5.87 · Sale (S): 386 @ $5.71 · Sale (S): 1 @ $5.70 | EDGAR |
| 2026-01-26 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 124,330 @ $0 · Grant/award (A): 186,500 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-02-28 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2022-10-14 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Code (U): 47,950 · Disposition to issuer (D): 67,000 (derivative) · Disposition to issuer (D): 38,930 (derivative) | EDGAR |
| 2022-03-02 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Grant/award (A): 25,950 @ $0 · Grant/award (A): 38,930 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Grant/award (A): 22,000 @ $0 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1308911 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs